Targeting Focal Adhesion Kinase in Neuroblastoma

Author(s): Lauren Gillory, Elizabeth A. Beierle

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 10 , Issue 10 , 2010

Become EABM
Become Reviewer
Call for Editor


Neuroblastoma is the most common extracranial solid tumor encountered in children, and continues to carry a dismal prognosis. Focal adhesion kinase (FAK) has been shown to be upregulated in a number of human tumors and is related to tumor virulence and patient prognosis. We have demonstrated FAK expression in human neuroblastoma cell lines and tumors, and have shown that FAK is important for neuroblastoma tumor cell viability. We have also demonstrated that FAK inhibition through a number of different methods results in decreased neuroblastoma survival both in vitro and in vivo. The current review addresses the merit of further exploring FAK inhibition as a novel treatment for neuroblastoma.

Keywords: C4, FAK, neuroblastoma, NVP-TAE226, Y15, Cellular Adhesion, VEGFR, MHC, NCAM, MYCN, SKP, chloropyramine hydrochloride, tumor

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [714 - 721]
Pages: 8
DOI: 10.2174/187152010794728684
Price: $65

Article Metrics

PDF: 14